Allogeneic hematopoietic SCT performed in non-HEPA filter rooms: Initial experience from a single center in India

Bone Marrow Transplantation

Volumn 43, Issue 2, 2009, Pages 115-119

  Kumar, R ^a   Naithani, R ^a   Mishra, P ^a   Mahapatra, M ^a   Seth, T ^a   Dolai, T K ^a   Bhargava, R ^a   Saxena, R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN; AMPHOTERICIN B LIPID COMPLEX; BUSULFAN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; FLUCONAZOLE; FLUDARABINE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; THYMOCYTE ANTIBODY; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; ASPERGILLOSIS; BACTERIAL INFECTION; BLOOD CULTURE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENGRAFTMENT; FEMALE; FEVER; FILTER; GRAFT REJECTION; HEALTH CARE FACILITY; HEALTH CENTER; HEMATOPOIETIC STEM CELL; HUMAN; INDIA; MALE; MORTALITY; MYCOSIS; MYELODYSPLASTIC SYNDROME; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; THALASSEMIA MAJOR; TUBERCULOSIS;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FILTRATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INDIA; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PATIENT ISOLATION; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; VENTILATION; YOUNG ADULT;

EID: 59549106857     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.307     Document Type: Article

References (15)

1. Sullivan KM, Dykewicz CA, Longworth DL, Boeckh M, Baden LR, Rubin RH et al. Preventing opportunistic infections after hematopoietic stem cell transplantation: The Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am Soc Hematol Educ Program 2001, 392-421.
2. Hayes-Lattin B, Leis JF, Maziarz RT. Isolation in the allogeneic transplant environment: How protective is it? Bone Marrow Transplant 2005; 36: 373-381.
3. Russell JA, Chaudhry A, Booth K, Brown C, Woodman RC, Valentine K et al. Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: A 10-year experience. Biol Blood Marrow Transplant 2000; 6: 109-114.
4. Svahn BM, Remberger M, Myrback KE, Holmberg K, Eriksson B, Hentschke P et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002; 100: 4317-4324.
5. Jeena MI, Deepa P, Mujeeb Rahiman KM, Shanthi RT, Hatha AAM. Risk assessment of heterotrophic bacteria from bottled drinking water sold in Indian markets. Int J Hyg Environ Health 2006; 209: 191-196.
6. Kumar R, Prem S, Mahapatra M, Seth T, Chowdhary DR, Mishra P et al Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. Bone Marrow Transplant 2006; 37: 745-749.
7. Kothari A, Ramachandran VG, Gupta P, Singh B, Talwar V. Seroprevalence of cytomegalovirus among voluntary blood donors in Delhi, India. J Health Popul Nutr 2002; 20: 348-351.
8. Chandy M, Srivastava A, Dennison D, Mathews V, George B. Allogeneic bone marrow transplantation in the developing world: Experience from a center in India. Bone Marrow Transplant 2001; 27: 785-790.
9. Pande JN, Bhatta N, Biswas D, Pandey RM, Ahluwalia G, Siddaramaiah NH et al. Outdoor air pollution and emergency room visits at a hospital in Delhi. Indian J Chest Dis Allied Sci 2002; 44: 13-19.
10. Nidhi, Jayaraman G. Air quality and respiratory health in Delhi. Environ Monit Assess 2007; 135: 313-325.
11. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: Antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005; 142: 979-995.
12. Dykewicz CA. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 2001; 33: 139-144.
13. Trifilio S, Verma A, Mehta J. Antimicrobial prophylaxis in hematopoietic stem cell transplant recipients: Heterogeneity of current clinical practice. Bone Marrow Transplant 2004; 33: 735-739.
14. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175: 1459-1466.
15. Locasciulli A, Oneto R, Bacigalupo A, Socie G, Korthof E, Bekassy A et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: A report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2007; 92: 11-18.